GVCAX
Price
$10.71
Change
-$0.12 (-1.11%)
Updated
Jun 13 closing price
Net Assets
211.94M
JVMTX
Price
$27.57
Change
-$0.32 (-1.15%)
Updated
Jun 13 closing price
Net Assets
21.46B
Interact to see
Advertisement

GVCAX vs JVMTX

Header iconGVCAX vs JVMTX Comparison
Open Charts GVCAX vs JVMTXBanner chart's image
Gabelli Value 25 AAA
Price$10.71
Change-$0.12 (-1.11%)
VolumeN/A
Net Assets211.94M
JHancock Disciplined Value Mid Cap R4
Price$27.57
Change-$0.32 (-1.15%)
VolumeN/A
Net Assets21.46B
GVCAX vs JVMTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVCAX vs. JVMTX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCAX is a Buy and JVMTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 21.5B vs. GVCAX (212M). JVMTX pays higher dividends than GVCAX: JVMTX (0.67) vs GVCAX (0.51). GVCAX was incepted earlier than JVMTX: GVCAX (15 years) vs JVMTX (12 years). GVCAX (1.45) is less costly to investors than JVMTX (1.11). JVMTX is a more actively managed with annual turnover of: 47.00 vs. GVCAX (5.00). JVMTX has a lower initial minimum investment than GVCAX: JVMTX (0) vs GVCAX (1000). GVCAX annual gain was more profitable for investors over the last year : 11.71 vs. JVMTX (-3.01). JVMTX return over 5 years is better than : 51.48 vs. GVCAX (-5.46).
GVCAXJVMTXGVCAX / JVMTX
Total Expense Ratio1.451.00145%
Annual Report Gross Expense Ratio1.451.11131%
Fund Existence15 years12 years-
Gain YTD8.6212.453351%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets212M21.5B1%
Annual Yield % from dividends0.510.6777%
Returns for 1 year11.71-3.01-390%
Returns for 3 years-5.8516.50-35%
Returns for 5 years-5.4651.48-11%
Returns for 10 years-40.9035.66-115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETNB10.410.79
+8.21%
89bio
KRON0.890.01
+1.43%
Kronos Bio
AGS12.37N/A
N/A
PlayAGS
SYK377.30-3.19
-0.84%
Stryker Corp
HALO53.98-0.56
-1.03%
Halozyme Therapeutics